CNTA vs CVX · $6.15B cap vs P/E 17, rev $118.66B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
CNTA currently screens at market cap $6.15B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the CNTA and CVX stock pages for the full models.
Not investment advice.